Efficiently organized validation of technological processes according to international standards is an integral part of the life cycle of pharmaceutical production, one of the processes in the quality management system of modern pharmaceutical companies, and incorporates the approaches set forth in the rules of Good Manufacturing Practice (GMP) and ISO 9000 series standards [1, 2] Requirements of Good Manufacturing Practice (GMP) are measures to ensure the quality of products through which the appropriate organization of production and quality standards are achieved, taking into account the intended nature of the use of these drugs and requirements. The GMP guideline is that quality is built in in the process of products manufacturing, and not only controlled in the finished product. Validation and qualification are just that section of the GMP rules, which provides control of both the state of technological systems, equipment and processes, and the order of testing, which allows the production of invariably high-quality products [3] . Validation of technological processes in accordance with the requirements of good manufacturing practice is carried out in order to confirm that a process, personnel actions and the functioning of systems that provide this technological process are fully consistent with the purpose and allow obtaining the expected results. Each stage of drugs manufacture should serve as a convincing evidence that the process of its production occurs in accordance with the designed plan. Validation studies should be carried out in accordance with established procedures. Results and conclusions should be logged. If a new production formulation or manufacturing method is being introduced, then actions that demonstrate their suitability for routine (serial) production should be performed. It has to be proven that the established process with the use of specific materials and equipment permits continuous release of products of the required quality. Significant changes in the manufacturing process, equipment or materials must be validated [3] .
An important condition for obtaining a high-quality medicinal product is the definition of critical points and parameters of the production process, which is divided into several successive stages.
The purpose is to determine the critical parameters of the technological stages of obtaining tablets based on the dry extract of the Scutellaria baicalensis and hard gelatine capsules on the basis of native raw material -roots and rhizomes of Scutellaria baicalensis; to establish critical limits when introducing the obtaining technology into industrial production, which will allow obtaining high-quality, effective, safe and affordable preparations with nootropic action.
M a t e r i a l s a n d m e t h o d s
The subject of our research was the technological process of obtaining tablets based on dry extracts of roots and rhizomes of Scutellaria baicalensis. We have identified the critical parameters of the technological process for each stage. Validation tests were carried out for the determined critical parameters and the eligibility criteria were calculated.
Pharmacological and technological properties of the tablet masses and the finished pharmaceutical form have been studied according to the methods of the SPU [4] .
The quality of the resulting tablets and capsules was evaluated by such indicators as: appearance, identification, average mass, homogeneity of mass, decomposition, dissolution, erosion, microbiological purity, quantitative determination. Methods for assessing the quality of the drug were: visual, gravimetry, spectrophotometry.
The ranges of critical parameters have been determined according to the experimental data obtained.
R e s u l t s a n d d i s c u s s i o n
At the stage of the pharmaceutical development of tablets and capsules, a detailed analysis of each stage of the technological process was conducted to establish parameters to be monitored during the introduction into industrial production and during validation of the manufacturing process. One of the most important are the stages for tableting (encapsulation) mass preparation and the subsequent tabletting (encapsulation), so the parameters and characteristics of these operations are critical.
The development of a method for obtaining preparations in the form of tablets (direct compression or wet granulation method) depends on the crystallographic, physico-chemical and pharmaco-technological properties of active substances, excipients and quality requirements to the final dosage form, which must be stable and have certain therapeutic effect.
Researches conducted on the study of active, auxiliary substances, the determination of the methods for obtaining tablets and capsules are presented in [5, 6] , have allowed determining rational compositions and critical parameters.
Active substances, auxiliary substances and materials that are part of tablets and capsules are tested for compliance with the requirements of the SPU or TC (entrance control).
At the stage of raw material preparation in the manufacture of tablets, the control of the size of the holes of the screen was monitored and the quality of screening was evaluated. The weight of each ingredient was loaded according to the production formula. To make the humidifier using measuring tank measure the required amount of water heated to 30 °C and polyvinylpyrrolidone. Mixed to obtain a homogeneous clear solution 10 ± 1 min.
The mixing of the components at the stage of mass moistening and granulation of the dosage form is carried out in a mixer-granulator. Weighed and sieved substances were loaded with Vacuum. Humidifier was added and mixed to a homogeneous distribution of components. The rotation speed of the mixer was 20 rpm, the wetting time 10 ± 2 min. The drying time of the mass was 35-40 min at a drying temperature of 50 ± 5 °C to a residual moisture of granules 3.5 ± 0.5%, which was determined every 15 minutes. Calibration was carried out through a sieve with mesh size 1.5-2.0 mm.
At the stage of granulate powdering, the process was carried out with calculated amount of mixture, containing silica, talc, calcium stearate and sodium croscarmellose for 5 ± 2 min. In the resulting intermediate product, the appearance, quantitative content, homogeneity of the active substance distribution, and the quality of powdering were determined.
At the tabletting and dust control stage, the compression force and the weight of the tablets were monitored and control of the intermediate product of the tablets (description, average weight of tablets, homogeneity of the tablet weight, diameter, height, mechanical strength, friability, quantitative content, disintegration and dissolution) was performed.
At the packing stage, the temperature of the cells formation and the temperature of PVC and foil the rmowelding were monitored. The resulting tablets were controlled for the number of tablets in a blister, the correct labelling, the quality of the packages and their tightness.
At the boxing stage, controlled the number of blisters in a box and the correct marking. In the production of capsules based on native raw material, the grinding and sieve mesh control 0,500 ± 0,050 mm were performed at the raw material preparation and sifting stage.
Mixing of the components of the dosage form was carried out in a mixer. Loaded with vacuum weighted and sieved materials. The process of mixing the mixture was carried out in a mixer (bin). The loading sequence and mixing time, which was 30 ± 1 min at a rotational speed of 8 rpm, was monitored and the quality of the semi-finished product was controlled by the following parameters: appearance, quantitative content, moisture content in mass for encapsulation.
At the encapsulation stage, the size of the capsule and the weight of the capsule content were monitored. The resulting capsules were subjected to quality control of intermediate products (appearance, average mass, quantitative content).
During the packing of capsules in a cellular package, the parameters of cells formation temperature (120-135 °С) and the temperature of the thermal sticking of PVC and foil (165-175 °С) were controlled. The resulting capsules were controlled for the number of capsules in a blister, the correct labelling, the quality and tightness of the package.
At the boxing stage, control was carried out on the number of blisters in a box and the correct labelling.
The critical parameters of the developed technological processes of production are given in tables 1 and 2. Technological schemes of production of drugs are shown in Fig. 1 The proposed technological scheme of drugs production has a high stability of the given characteristics and their low variability, depending on the change in technological and pharmaco-technological characteristics of the intermediates within the limits of the proposed projected field of the final product quality characteristics, which is confirmed by dissolution profiles with repetition of the results.
Taking into account the results of the validation tests, it can be concluded that the established values of the critical parameters of the technological process of producing tablets based on the dry extract of the Baikal skullcap and hard gelatin capsules on the basis of the native raw material and the conditions for their implementation allow stable and guaranteed obtaining of intermediate and finished products meeting the quality parameters according to reference documents. Validation data of experimental and industrial series meet the eligibility criteria, and the developed technology is reproducible and promising for further validation.
C o n c l u s i o n s 1. In the process of production of tablets based on the dry extract of scullcap and solid gelatin capsules on the basis of crushed plant material, critical parameters have been determined that significantly affect the quality of the resulting preparation.
2. The conducted validation research of the technological process allow guaranteeing the quality of the received drugs and the subsequent reproducibility of the technological process.
Fig. 2. Technological flowchart of capsules production
The proposed technological scheme of drugs production has a high stability of the given characteristics and their low variability, depending on the change in technological and pharmaco-technological characteristics of the intermediates within 
B S T R A C T
An important condition for obtaining a high-quality drug is the determination of critical points and parameters of the production process, which is divided into several successive stages.
The aim study of the critical parameters of the production of tablets and capsules with vegetable raw materials. For this purpose, validation studies of technological processes were carried out for tablets with dry extract of Scutellaria baicalensis and hard gelatin capsules with vegetable raw materials.
The subject of our research was the technological process of obtaining tablets based on dry extract of the roots and rhizomes of Baikal skullcap and hard gelatin capsules based on crushed raw materials. We have identified critical process parameters for each stage. Validation tests were carried out for certain critical process parameters and acceptance criteria were calculated.
Quality control of finished tablets based on dry extract of Baikal skullcap and finished hard gelatin capsules based on crushed roots and rhizomes of Baikal skullcap was performed according to the following indicators: appearance, identification, average weight, mass uniformity, disintegration, dissolution, abrasion, microbiological purity, quantitative determination .
The obtained validation data of experimental-industrial series meet the acceptance criteria, and the developed technology is reproducible and promising for further validation.
On the basis of the obtained results, it can be concluded that the established critical values of the parameters of the production processes and their conditions of carrying out allow for stable and reliable production of semi-finished and finished products that meet the quality standards in accordance with regulatory documents. Метою досліджень є вивчення критичних параметрів виробництва таблеток і капсул із рослинною сировиною. З цією метою здійснювали валідаційні дослідження технологічних процесів для таблеток із сухим екстрактом Scutellaria baicalensis і твердих желатинових капсул із рослинною сировиною.
Предметом нашого дослідження був технологічних процес одержання таблеток на основі сухого екстракту коренів та кореневищ шоломниці байкальської і твердих желатинових капсул на основі подрібненої сировини. Нами було визначено критичні параметри технологічного процесу для кожної стадії. Для визначених критичних параметрів технологічного процесу виконували валідаційні випробовування та розраховували критерії прийнятності.
На етапі фармацевтичної розробки таблеток та капсул було зроблено детальний аналіз кожної стадії технологічного процесу з метою встановлення параметрів, що підлягають моніторингу під час впровадження у промислове виробництво та у разі валідації технологічного процесу виготовлення. Одними із найважливіших є стадії приготування маси для таблетування (капсулювання) і наступне таблетування (інкапсулювання), тому параметри і характеристики цих операцій є критичними.
Контроль якості готових таблеток на основі сухого екстракту шоломниці байкальської та готових твердих желатинових капсул на основі подрібнених коренів та кореневищ шоломниці байкальської виконували за такими показниками: зовнішній вигляд, ідентифікація, середня маса, однорідність маси, розпадання, розчинення, стираність, мікробіологічна чистота, кількісне визначення.
Запропонована технологічна схема одержання препаратів має високу стійкість заданих характеристик і їхню низьку варіабельність залежно від зміни технологічних і фармакотехнологічних характеристик напівпродуктів у межах запропованого проектованого поля характеристик якості кінцевого продукту, що підтверджується профілями розчинення з повторенням результатів.
Отримані дані валідації дослідно-промислових серій відповідають критеріям прийнятності, а розроблена технологія є відтворюваною та перспективною для подальшої валідації.
На підставі отриманих результатів можна зробити висновок, що встановлені критичні значення параметрів виробничих процесів і умови їх проведення дають змогу стабільно і надійно одержувати напівпродукти і готові продукти, які відповідають нормам якості згідно з нормативними документами.
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Целью исследований является изучение критических параметров производства таблеток и капсул с растительным сырьем. С этой целью проводили валидационные исследования технологических процессов для таблеток с сухим экстрактом Scutellaria baicalensis и твердых желатиновых капсул с растительным сырьем.
Предметом нашего исследования был технологических процесс получения таблеток на основе сухого экстракта корней и корневищ шлемника байкальского и твердых желатиновых капсул на основе измельченного сырья. Нами были определены критические параметры технологического процесса для каждой стадии. Для определенных критических параметров технологического процесса выполняли валидационные испытания и рассчитывали критерии приемлемости.
На этапе фармацевтической разработки таблеток и капсул был осуществлен детальный анализ каждой стадии технологического процесса с целью установления параметров, подлежащих мониторингу при внедрении в промышленное производство и при проведении валидации технологического процесса изготовления. Одними из важнейших являются стадии приготовления массы для таблетирования (капсулирования) и последующее таблетирование (инкапсулирование), поэтому параметры и характеристики этих операций являются критическими.
Контроль качества готовых таблеток на основе сухого экстракта шлемника байкальского и готовых твердых желатиновых капсул на основе измельченных корней и корневищ шлемника байкальского осуществляли по следующим показателям: внешний вид, идентификация, средняя масса, однородность массы, распадаемость, растворение, истираемость, микробиологическая чистота, количественное определение.
Предложенная технологическая схема получения препаратов имеет высокую устойчивость заданных характеристик и их низкую вариабельность в зависимости от изменения технологических и фармакотехнологических характеристик полупродуктов в пределах проектируемого поля характеристик качества конечного продукта, что подтверждается профилями растворения с повторением результатов.
Полученные данные валидации опытно-промышленных серий соответствуют критериям приемлемости, а разработанная технология воспроизводимой и перспективной для дальнейшей валидации.
На основании полученных результатов можно сделать вывод, что установленные критические значения параметров производственных процессов и условия их проведения позволяют стабильно и надежно получать полупродукты и готовые продукты, которые соответствуют нормам качества согласно нормативным документам.
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